ADDvise acquires Labplan Ltd.

22-12-2023   Regulatory press release

ADDvise Group has entered into a share purchase agreement with the owners of Labplan Ltd. (“Labplan”) regarding the acquisition of all shares of Labplan. Closing takes place today.

Labplan, based in Kildare, Ireland, is a distributor of specialized advanced instruments, consumables and service to the life science and biopharmaceutical industry. The company serves large multi-national pharma companies as well as government-backed research institutions in Ireland and Northern Ireland.

Labplan’s revenue for the last twelve months per October 31, 2023, amounted to EUR 16.9 million, with an adjusted EBITDA of EUR 3.9 million, corresponding to an adjusted EBITDA margin of 23.0 percent.

The acquisition will be consummated at an initial cash consideration of EUR 13.3 million, and performance-based payments expected to amount to EUR 7.2 million in aggregate over a two-year period.

The acquisition is financed through own funds. ADDvise assesses that the acquisition will have a positive impact on ADDvise’s earnings per share during the financial year 2024.

Adviser

Mangold Fondkommission AB acted as financial adviser to ADDvise in connection with the acquisition.

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Hanna Myhrman, General Counsel
+46 709 82 92 23
hanna.myhrman@addvisegroup.se

Important information

This information is information that ADDvise Group AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on December 22, 2023 at 17:40 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise publishes prospectus in connection with a rights issue

Regulatory

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES), AUSTRALIA, CANADA, BELARUS, HONG KONG, JAPAN, NEW ZEALAND AND RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL,…

Report from the extra ordinary general meeting in ADDvise Group AB (publ)

Regulatory

ADDvise Group AB (publ), reg. no. 556363-2115 (the "Company"), has held an extraordinary general meeting on 12 March 2025. The general meeting resolved to amend the articles of association, approve the board's resolution regarding a rights issue of shares of series A and series B, approve the board's resolution on a directed issue of warrants…

Year-end report 2024, January 1–December 31

Regulatory

The fourth quarter of 2024 showed a turnaround in organic net revenue. In December alone, we are now back at positive organic growth of 4.8%. With new long-term financial targets, we are now taking the next step in the company’s development, with a continued focus on profitable growth, stable returns and well-balanced debt.

Notice to extraordinary general meeting of ADDvise Group AB (publ)

Regulatory

ADDvise Group AB (publ), reg. no 556363–2115, hereby convenes the extraordinary general meeting on 12 March 2025 at 10:00 CET at Grev Turegatan 30 in Stockholm. Entrance and registration start at 09:30 CET. Shareholders wishing to attend the general meeting must: i)          be registered in the share register kept by Euroclear Sweden on the record…